Form 4: Saul Centers Director Mark Sullivan III Reports Acquisition of Restricted Stock
SEC Form 4 Filing
Mark Sullivan III, a director at Saul Centers, Inc., reported the acquisition of 2,000 shares of restricted common stock on May 17, 2024.
Summary
- On May 21, 2024, Mark Sullivan III, a director of Saul Centers, Inc. [BFS], filed a Form 4 with the SEC.
- The report details a transaction on May 17, 2024, where Mr. Sullivan acquired 2,000 shares of common stock.
- These shares are restricted and will vest in equal annual installments over the first three anniversaries of May 17, 2024, contingent upon continued service.
- Mr. Sullivan also holds shares indirectly through a trust (800 shares), an IRA (8,510.323 shares), and a SEP IRA (1,463.092 shares).
- The filing also clarifies that previous reports referred to 'Common Shares,' which will now be referred to as 'Common Stock'.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of insider transactions. The acquisition of restricted stock is generally viewed positively as it aligns the director's interests with the company's long-term performance, but it's not a major event.
Positives
- The acquisition of restricted stock aligns the director's interests with the long-term performance of the company.
- The vesting schedule incentivizes continued service and commitment from the director.
Future Outlook
The restricted shares will vest over the next three years, contingent on continued service.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to monitor the actions of those with privileged information.
Comparison to Industry Standards
- Comparing Saul Centers to similar REITs like Federal Realty Investment Trust (FRT) or Regency Centers Corporation (REG), insider ownership and stock option grants are common practices to align management and shareholder interests.
- The vesting schedules for restricted stock are generally in line with industry norms, typically ranging from three to five years.
Stakeholder Impact
- The acquisition of restricted stock by a director can be viewed positively by shareholders as it aligns management's interests with the company's performance.
- The vesting schedule incentivizes the director to remain with the company, providing stability.
Key Dates
| Date | Description |
|---|---|
| 05/08/2015 | Date exercisable for Director Stock Option at $51.07, expiring 05/08/2025 |
| 05/06/2016 | Date exercisable for Director Stock Option at $57.74, expiring 05/06/2026 |
| 05/05/2017 | Date exercisable for Director Stock Option at $59.41, expiring 05/05/2027 |
| 05/11/2018 | Date exercisable for Director Stock Option at $49.46, expiring 05/11/2028 |
| 05/03/2019 | Date exercisable for Director Stock Option at $55.71, expiring 05/03/2029 |
| 04/24/2020 | Date exercisable for Director Stock Option at $50, expiring 04/24/2030 |
| 05/07/2021 | Date exercisable for Director Stock Option at $43.89, expiring 05/07/2031 |
| 05/13/2022 | Date exercisable for Director Stock Option at $47.9, expiring 05/13/2032 |
| 05/12/2023 | Date exercisable for Director Stock Option at $33.79, expiring 05/12/2033 |
| 05/17/2024 | Date of transaction: Acquisition of 2,000 restricted shares of common stock; vesting starts on this date over three years. |
| 05/21/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.